Authors
Latest:
Next-gen lasers and IOLs for every patient: the year ahead in corneaWhy “acceleration” is the industry keyword for 2024
Latest:
Sustained-release anti-inflammatory therapy proves valuable in NIULong-term treatment helps chronic, vision-threatening disease.
Latest:
Treating anisometropic amblyopia with a dichoptic digital platformThe investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age
Latest:
Insights into the future of eye careA UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.
Latest:
Clinical outcomes and patient satisfaction achieved with a corneal approach for managing presbyopia – a case with special significanceDr. Arnaldo Espaillat decided to undergo ZEISS PRESBYOND and shares how his own experience led him to expand his refractive portfolio with this corneal-based approach for patients without cataracts.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
A new set of guidelines for implementing interventional glaucomaThe framework covers ocular hypertension to severe progression
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Novel Intravitreal Injections: Faricimab and Aflibercept 8mg for the Treatment of Retinal DiseasesPanelists discuss how novel intravitreal agents faricimab and high-dose aflibercept 8mg offer potential advantages in treating retinal diseases through their extended durability and dual mechanism of action.
Latest:
Pearls for management of Pseudomonas scleritisDr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
Latest:
New goniotomy device + careful post-op care limits intraoperative bleedingA new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.
Latest:
Worldwide pathological myopia discussed by panel at EURETINA 2021Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Global partnership targets ROP in premature infantsAn AI-supported telemedicine effort from Siloam Vision and Orbis International
Latest:
New options are on the horizon for presbyopia-correcting dropsFor ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Latest:
Harnessing digital media for enhanced patient engagement and outcomesPatients who received digital education demonstrated a better understanding of their disease and its management
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Zooming in on geographic atrophy with OCT-based AINew analysis brings disease progression and therapeutics into focus
Latest:
Six-year findings from laser in glaucoma and ocular hypertension (LiGHT)In visual field progression results, SLT was superior to ocular drops as first-line treatment for patients with glaucoma
Latest:
Optimizing diagnosis and surgical management of diabetic retinopathy using advanced imaging technologiesDiabetic Retinopathy ranked as the fifth most common cause of blindness among adults aged 50 and older in 2020 according to data from the Global Burden of Disease study. Aude Couturier, MD shares her experience of using advanced imaging technologies to optimize diagnosis and surgical management of her DR patients in our latest Case of the Month.
Latest:
Letter to the Editor: Intravitreal injections. Who should perform them?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
Back to the cornea – Treating hyperopic patients with Lenticule ExtractionLenticule Extraction for treating patients with hyperopia is now available with SMILE® pro, performed on the VISUMAX® 800 from ZEISS. This additional option provides a valuable corneal-based alternative for younger patients without cataract. In this Case of the Month, you will discover the advantages of this procedure and review the outcomes of a 30-year-old patient who chose to undergo Lenticule Extraction with ZEISS SMILE pro after experiencing discomfort with contact lenses for many years.
Latest:
First-ever retinal gene therapy: Does real-world experience back its use?Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Latest:
Focusing on functional vision with monofocal lensesQuantitative and qualitative improvement in IOL design
